H2 Pharma was founded in 2007 by two senior Pharmaceutical Executives: Hiep Huatan and Jane Hua (nee Mackay). Their principal business objective is to be one of the most innovative Consultancy Group providing specialised product development services to the Biotech and Pharmaceutical Industry, Research Institutions and Academia.
With over 25 years collective experience gained in large pharmaceutical organisations (Pfizer, GSK), biotechnology start-up (Phoqus) and clinical CROs (Innovex, Quintiles and Icon), Hiep Huatan (former Vice President, R&D at Phoqus) and Jane Hua (Former Clinical Project Director at Quintiles) have extensive product development experience. Their knowledge base spans the breadth of the drug discovery and development process from preclinical research through to exploratory, full development and product registration. Both have been pivotally involved in a number of commercially successful human health and animal health product development programmes including: RevatioTM, ExuberaTM, ActosTM, LamictalTM, RevolutionTM, DectomaxTM and CereniaTM.
Their key areas of expertise include:
►
Drug discovery support and preclinical
development
►
Clinical operation and project management
►
Formulation, analytical and manufacturing
►
Regulatory CMC
►
Intellectual Property (IP) development and
management
►
R&D programme planning and management
►
External resources procurement and management
Hiep Huatan and Jane Hua are also well connected within the pharma and biotech industry, having access to a wide network of freelance consultants and contract research and manufacturing organisations.
For more information on our services [click here] or [contact us]
For more information on our services